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Background: Right-sided cardiac masses are infrequent and have varied clinical presentation.
The present study describes the clinical features, echocardiographic findings andmanagement
of 19patientspresentingwith right-sidedcardiac thrombi ina tertiary care center innorth India.
Methods: This is a retrospective, single center observational study of consecutive patients
over the period January 2003e2008 admitted in our emergency intensive care unit (EICU).We
identified 38 patients with right-sided cardiac masses admitted to EICU diagnosed by
transthoracic echocardiography of which 19 patients had right-sided thrombus. The echo-
cardiographic findingswere reviewed by two cardiologists in all patients. Treatmentwas not
standardized and choice of therapy was based on judgment of attending physician.
Results: The mean age of patients with cardiac thrombus was 36.6  11.8 years. Right atrial
(n ¼ 17) and right ventricle (n ¼ 2) thrombi were associated with deep vein thrombosis
(DVT) in 7 (36.8%) and pulmonary embolism in 3 (15%) patients. 13 (68.4%) patients
appeared to have in situ mural thrombus. 12 patients were managed with oral anticoag-
ulants, 3 patients underwent surgery and 4 patients were thrombolysed. All the survivors
had a mean follow-up of 40  6 months (range e 18e50 months).
Conclusions: Prompt echocardiographic examination inanappropriate clinical setting facilitates
faster diagnosis andmanagement of patients with right-sided cardiac thrombi. High incidence
of in situmural thrombus and varied comorbidities predisposing to right-sided cardiac thrombi
besides DVT and pulmonary embolism need to be recognized. Oral anticoagulation and
thrombolysis appear to be themainstay of treatmentwith surgery limited for selected patients.
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i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 5 2 9e5 3 5530Right-sided cardiac masses are infrequent and do not have a
uniform clinical presentation. High index of suspicion and
prompt echocardiographic examination in an appropriate
clinical settingshall facilitate fasterdiagnosisandmanagement
of patientswith right-sided cardiac thrombi. The present study
describes the clinical features, echocardiographic findings and
management of 19 patients presentingwith right-sided cardiac
thrombi in a tertiary care center in north India.1. Methods
This is a retrospective, single center study of all consecutive
patients admitted in our EICU from Jan 2003e2008. We identi-
fied 38 patients with right-sided cardiac masses admitted to
EICUdiagnosed by transthoracic echocardiography ofwhich 19
patients had right-sided thrombus. Masses such as vegetation,
primary or metastatic tumors and embryological remnants
were excluded.
Trans-thoracic echocardiography was done in all patients
using a Philips Envisor with a 2.5- or 3.5-MHz probe. Six patients
also underwent trans-esophageal echocardiography (TEE) using
a 5-MHzmonoplane echo probe. CardiacMRI was needed in one
patient to differentiate it frommyxoma. All patients underwent
vascular Doppler studies, D-dimer assay (by enzyme linked
immunosorbant assay [ELISA]) and three blood cultureswith the
first and last one at least half an hour apart. Ventilation perfu-
sion (VQ) scan was done in 10 patients where high pulmonary
artery (PA) pressures or dilation of right ventricle (RV) or exces-
sive mobility of themass pointed to the possibility of associated
pulmonary thromboembolism. The 9 patients who did not un-
dergo VQ scan included 4 patientswith rheumatic heart disease,
1 with RV cardiomyopathy, 2 patients with constrictive pericar-
ditis and 2 patients with sepsis where possibility of pulmonary
embolism was unlikely in presence of alternative diagnosis.2. Results
Out of 38 patients identified with right-sided cardiac masses
19 had right-sided thrombus. The mean age of patients with
cardiac thrombus was 36.6  11.8 years (age range e 7 days to
64 years; median age e 33 years). There were 7 female and 12
male patients. Clinical and echocardiographic findings of pa-
tients are presented in flowcharts (Figs. 1 and 2).
All patients presented with dyspnea; 10, 6 and 3 patients
were in NYHA class II, III and IV, respectively at presentation.
One patient each presented with palpitations and easy fati-
gability. Pulmonary arterial hypertension (PAH) was present
in 17 patients at presentation. Ten patients (52.6%) presented
with mild PAH and 7 patients presented with moderate to
severe PAH. The severity of PAH was classified on the basis of
mean pulmonary artery pressure as mild (25e40 mmHg),
moderate (41e55 mmHg) or severe (>55 mmHg).1
In all, 36.8% (n ¼ 7) patients presented with deep venous
thrombosis (DVT); with ileo-femoral DVT (n ¼ 2), ileo-femoral
and popliteal (n ¼ 1) and popliteal vein (n ¼ 4) involvement.
One patient had a history of DVT 3 years ago which was not
present during the time of enrollment. This patient had
developed right atrial (RA) thrombi while he was on oralanticoagulants. 15% (n ¼ 3) patients with right-sided thrombi
had evidence of pulmonary embolism.
Only 21% (n ¼ 4) patients had a history of prolonged
immobilization and three of these had associated DVT.
Similar number of patients (n ¼ 4) had associated tuberculosis
[pleural effusion 1, pott’s spine 1, tubercular chronic
constrictive pericarditis (CCP) 2], and half of these had asso-
ciated large vein occult DVT.
Two patients presented with sepsis and infected RA
thrombus. One of these patients was a 7 days female, pre-
sentingwithcerebrovascular accident followingumbilical vein
cannulationandotherpatientpresentedwithpyopericardium,
pyomyositis and history of acute febrile illness. Four patients
hadassociated rheumaticheartdiseaseall ofwhomhadsevere
mitral stenosis with associated RV dysfunction (n ¼ 1), left
ventricle (LV) dysfunction (n¼ 1) left atrial (LA) thrombus (n¼ 1)
and organic tricuspid valve disease (n ¼ 1). Associated malig-
nancy (carcinoma (CA) breast post-irradiation and surgery),
connective tissue disease (Scleroderma with chronic throm-
boembolic pulmonary hypertension (CTEPH) with RV
thrombus), RV cardiomyopathy and human immunodefi-
ciency virus (HIV) positive status on follow-upwas detected in
one patient each. Three patients had associated RV dysfunc-
tion and 2 patients had LV systolic dysfunction.2.1. Imaging characteristics
The echocardiographic findings were recorded and reviewed
by two cardiologists in all patients. The right-sided thrombi
varied in size from 1.1  0.9 to 6  8.5 cm. Most of these were
regular (84%) with varying shapes {spherical (26%), oval/ovoid
(36%), vermicular (21%), rhomboid and spindle shaped}.
Broad-based pedicle could be identified in one of the cases,
rest were non-pedunculated. Barring 3 cases, the attachment
of thrombi could be localized from inferior vena cava (IVC)
opening (3/19), RA roof (3/19), Eustachian valve (2/19), inter
atrial septum (4/19), RV apex (2/19) and from body of RA and
RA appendage (2/19). Mobility was preserved in 6 of these with
2 thrombi extending across tricuspid valve and 1 across
tricuspid valve upto RV outflow tract. In 3 patients with patent
foramen ovale (PFO) the thrombi extended across tricuspid
valve and mitral valve; tricuspid, mitral and aortic valve; and
across mitral and aortic valve, respectively. Two patients (one
with scleroderma, CTEPH and other with RV myocardial
infarction and RV dysfunction) had right ventricle thrombi.
Mild and moderate to severe PAH was found in 52.6% (n ¼ 10)
and 36.8% (n ¼ 7) patients, respectively.3. Management and follow-up
Treatment was not standardized and choice of therapy was
based on judgement of attending physician. Twelve patients
were managed with oral anticoagulants, 3 patients underwent
surgery and 4 patients were thrombolysed. The dose of
thrombolytic agents used was e Streptokinase (STK) e intra-
venous (IV) bolus 250,000 units over 30min followedby infusion
of 100,000 units/h for 12e24 h and Recombinant tissue plas-
minogen activator (rtPA)e IV bolus of 15mg in 10min followed
Fig. 1
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mean follow-up of 40  6 months (range e 18e50 months).
Echocardiography, clinical examination and hypercoagu-
lability profile was obtained at 6 monthly visits. All the pa-
tients were kept on oral anticoagulants in long term with INR
maintained within 2.0e3.0.
Of the 17 survivors 15 patients had no right-sided thrombi
on echocardiography follow up at 6 months. Two patients had
persistence of thrombus; one of these had a history of DVT
3 years prior to presentation. The second patient had Inferior
wall and RV myocardial infarction (MI) with RV thrombi per-
sisting for first 6 months but thereafter completely dis-
appearing at 3rd visit (9months). Fungal and bacterial etiology,
respectively, was found in the two patients presenting with
infected RA thrombus (Fig. 3) and each of them responded to
heparin infusion along with prolonged parenteral antibiotics/
antifungals. Amongst the four patients presenting with severe
mitral stenosis (MS) (Fig. 4), two patients underwent balloon
mitral valvotomy (BMV) and mitral valve replacement (MVR)
successfully after 6 weeks of disappearance of RA thrombus.
The other two patients with severe MS were kept on medical
management. Both patients with chronic constrictive peri-
carditis (tubercular etiology) underwent surgery, received 9
months antitubercular treatment (ATT) and remained on oral
anticoagulation for one year (Fig. 5).
Three patientswith extension of thrombus into the left side
of heart (Fig. 6) were either thrombolysed (2 cases withstreptokinase) or sent for surgery (1 case). Onepatientwhowas
thrombolysed and the other patient who underwent surgery
expired immediately after thrombolysis and intraoperatively,
respectively. One survival in the medical group was free of
thrombi at 6months of followup. His thrombophilia profile for
inherited hyper coagulant states was negative though he was
continued on lifelong anticoagulation. Two patients with
thrombi extending across the TV up to the RV outflow tract
(RVOT) had associated pulmonary embolism and were suc-
cessfully thrombolysed.4. Discussion
Right heart thrombi can be classified into two groups. The first
group represents embolized deep venous thrombi that are
temporarily lodged in the right atrium or ventricle and are
often referred to as “emboli in transit” or thromboembolism
and the second group represents thrombi in situ or the mural
thrombi which are immobile. They present a distinctive
appearance on two-dimensional transthoracic and trans-
esophageal echocardiography. Since the initial case report by
Covarrubias2 and colleagues, many authors3e6 have described
thrombus in transit as highly mobile, coiled, or serpiginous
masses moving within the right atrium or ventricle. These
often prolapse into the tricuspid or pulmonic valve during the
cardiac cycle. A point of attachment often is unseen or is
Fig. 2 e Flow chart depicting imaging characteristics of right-sided masses and the treatment strategy.
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distinguish frommyxomas, and acoustic difference allows the
discrimination.5
Mural thrombi, show less motion during the cardiac cycle,
a broad-based attachment to the heart wall, and occasional
focal calcification. Mural RA thrombi are seen in conditionsFig. 3 e TTE image (sub costal view) showing round well
circumscribed heterogenous mass attached to inter atrial
septum in a seven day old new born.like cardiomyopathies, post coronary artery bypass grafting
(CABG), post atrial septal defect (ASD) repair, patients with
permanent pacemaker leads or hyper alimentation catheters
or ventriculoatrial shunts in situ.7 Such patients usually have
enlarged RA or decreased cardiac output with relative stasis of
blood or have evidence of endocardial damage to RA afterFig. 4 e TEE (bicaval view) showing oval homogenous mass
with translucency at periphery. Mass was immobile below
RA appendage in a patient of severe mitral stenosis, PAH
with severe RV systolic dysfunction.
Fig. 5 e TEE (bicaval view) showing irregular mobile sea
anemone like mass in protruding in right atrium in a
patient of constrictive pericarditis.
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and three had associated RV dysfunction.
The present study signifies the importance of high inci-
dence of in situ thrombus rather than thrombus in transit. The
incidence of mural thrombi is believed to be more in this se-
ries owing to characteristics of thrombi; n¼ 13 (68.4%) thrombi
were immobile with localized attachments as depicted in flow
chart. Moreover, underlying enlarged RA and decreased car-
diac output with relative stasis of blood predisposed to for-
mation of mural RA thrombi as in patients with severe mitral
stenosis and associated organic tricuspid valve disease, RV
dysfunction and LV dysfunction; constrictive pericarditis,
RV cardiomyopathy, Inferior and RV myocardial infarction
with RV dysfunction.
Most of the RA thrombi in this series were regular homog-
enous or multi lobed structures with or without central echo-
lucency. Theywere without a pedicle but appeared attached to
a particular point in right atrium or to one of the inlets in rightFig. 6 e TEE image (four chamber view) showing vermicular
mass moving across mitral value via PFO in a patient of
tubercular pneumonia and DVT.atrium. None of them was attached to the tricuspid leaflet,
though if mobile across the tricuspid valve they appeared to
move along the tricuspid leaflets into the RV in diastole unlike
vegetation on tricuspid leaflet. Unlike LV thrombus, none had a
layered appearance, except the RV thrombus. The infected
thrombus had a more heterogenous and mottled appearance,
were immobile without any extension, had a short clinical
history without significant immobilization and were not
associated with pulmonary embolization or any signs of
persistent bacteremia. The RV thrombi were immobile ho-
mogenous regular structures attached to the RV apex, taking
its shape and associated with RV dysfunction.
15% (n ¼ 3) patients were diagnosed to have pulmonary em-
bolism. Echocardiographic studies in patients with pulmonary
embolism show an incidence of right heart thromboembolism
between 3% and 23%, with a combined incidence of 9% across
several large series studying consecutive patients.8e12 On the
other hand, pulmonary thromboembolism may be seen up to
98%ofcasesof rightatrial thromboembolism.13177casesof right
heart thromboembolismwere analyzed ina retrospectivemeta-
analysis by Peter et al13 with pulmonary thromboembolism
present in98%of cases. The treatmentsadministeredwerenone
(9%),anticoagulation therapy(35.0%), surgicalprocedure (35.6%),
or thrombolytic therapy (19.8%). The overall mortality rate was
27.1%. The mortality rate associated with no therapy, anti-
coagulation therapy, surgical embolectomy, and thrombolysis
was 100.0%, 28.6%, 23.8%, and 11.3%, respectively. Using multi-
variate modeling, thrombolytic therapy was associated with an
improved survival rate (p < 0.05) when compared either to
anticoagulation therapy or surgery.
In the present study, right heart thrombi were associated
with mortality of 10.5% over 18-month follow up. Treatment
administeredwasonly anticoagulants in 12 (63%), thrombolysis
in 4 (21%), and surgery in 3 (15.7%) cases. Oral anticoagulation
remains to be the gold standard formural thrombus given their
success rate of 91.6% in dissolving such masses. Thrombolysis
should be given for compelling indications like right atrial
thromboembolism, pulmonary thromboembolism, increased
fragility andmobility of thesemasses, and extensionof thrombi
into left side across PFO. Surgery is indicated for indications
other than just mere presence of right-sided thrombus, for
instance, chronic constrictive pericarditis. Valve surgery and
simultaneous removal of RA clot is also recommended though
in the present series it was done only after resolution of clot.
The RA thrombi-behaves same as platelet rich red thrombi
disappearing slowly with oral anticoagulants or more early
with thrombolysis. Infected thrombus is a form intermittent
between a thrombus and vegetation caused by local seeding of
a thrombus by the highly virulent infected material during
transient bacteremia in appropriate clinical conditions. In the
present series, two patients had infected thrombi one with
pyomyositis and other with septicemia and a history of um-
bilical vein cannulation. One of these cases had an undulating
membrane over the RA thrombi. Thrombus is generally hypo
vascular tissue, so ingress of antibiotics and immune system
antibodies via vasculature is thought to be poor and prompt
surgical resection of the infected thrombus should be per-
formed, followed by prolonged administration of antibiotics.
However both our patients responded to antibiotics along
with oral anticoagulants.
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dian subcontinent and was seen in 21% cases. Half of these
cases also had associated DVT. Deep vein thrombosis was
occult in more than 50% of cases. Tuberculosis as a risk factor
for venous thrombosis has been mentioned in various stud-
ies.14e22 Deep vein thrombosis occurred in 50% of patients in a
series of 380 patients of tuberculosis along with various he-
matological abnormalities.23 The hypercoagulable state in
tuberculosis is caused by increased anti-phospholipid anti-
bodies, decreased protein C and protein S, decreased anti-
thrombin III, thrombocytosis, increased fibrinogen levels,
increased fibrinogen degradation products and t-PA causing
impaired fibrinolysis.15e17,20 Mechanical factors like lymph-
adenopathy causing venous obstruction and subsequent
thrombosis has also been reported, as is antitubercular drug
rifampicin causing hypercoagulable state.21,22
Patients having RA mass extending into the left side had
the worst prognosis of all. Two out of three patients in this
series expired with one immediately after thrombolysis while
the second one expired intraoperatively.
The most effective therapy for patients with right heart
thrombi remains unknown. This issue is critical because the
presence of a right heart thromboembolus complicating a
pulmonary thromboembolism appears to carry a poor prog-
nosis.3,5,6,24,25 Chartier et al8 reported amortality rate of 45% in
the most recent series of 38 consecutive patients with right
heart thromboembolism. All of these deaths occurred within
the first 24 h of hospitalization, signifying the need to rapidly
diagnose and treat right heart thromboembolism.8
Existing published reports differ in their recommendations
for treatment by advocating surgical removal,4,9 administra-
tion of thrombolytic agents8 or anticoagulation therapy24 with
heparin. The last analysis of patients with right heart
thromboembolism (n ¼ 119) found similar mortality rates for
surgery, thrombolysis, and heparin anticoagulation therapy
(38%, 38%, and 30%, respectively) and thus concluded that
heparin therapy was the treatment of choice.24
Unfortunately, there are no prospective trials to defini-
tively answer this question or to assess other risk factors that
may be related to mortality. Our results suggest that throm-
bolytic therapy was associated with a reduction in mortality
for thromboembolus while oral anticoagulation was enough
for mural thrombus. Oral anticoagulants alone for free
floating thrombus may be hazardous with the possibility of
thrombus embolizing to pulmonary circulation.
Surgical embolectomy has its own set of potential com-
plications including an inherent delay of at least hours, gen-
eral anesthesia, cardiopulmonary bypass, and the inability to
remove coexisting pulmonary thromboemboli beyond the
central pulmonary arteries. One of the major advantages of
the surgical approach is the ability to simultaneously repair a
PFO, thus reducing the risk of a subsequent paradoxical em-
bolism. The percutaneous catheter directed retrieval of clots is
a promising possibility, but only few cases have been reported
to date.26,27 In contrast, thrombolytic therapy can be admin-
istered quickly and results in the simultaneous thrombolysis
of cardiac and pulmonary arterial thromboemboli as well as a
thrombus in the femoral venous circulation. The major
complication of thrombolytic therapy is significant bleeding,
which occurs in as many as 22% of patients.285. Limitations
Thisstudyis relativelysmall sizedretrospectivestudywithwide
variability inclinicalaspectsof thestudiedpatients.However, in
absence of any previous published reports on the entity in this
region, our findingsmight be an impetus for future work in this
field. PE was diagnosed in 3 (15%) patients in the present study.
However, VQ scan employed for the diagnosis is not a sensitive
modality to detect small thrombi and hence there might be an
under estimation of the prevalence of PE. Also, of the 19 studied
patients, 9 patients did not undergo VQ scan as there were
alternative explanations available for PAHand/or RVdilatation.
These patients could still havehad PE. As regardsmanagement,
the treatment with thrombolysis and anticoagulation resulted
in good outcome in these patients with right heart thrombi,
most of which appeared to be mural thrombi. However, in the
small patient population comparison amongst the treatment
modalities was not possible. In our experience, thrombolysis
appears to be a bettermodality in patientswith severe PAH and
right-sided thrombi.6. Conclusion
Prompt echocardiographic examination in an appropriate clin-
ical setting facilitates faster diagnosis and management of pa-
tientswith right-sidedcardiac thrombi.High incidenceof in situ
mural thrombusandvariedcomorbiditiespredisposing to right-
sided cardiac thrombi besides DVT and pulmonary embolism
need to be recognized. Oral anticoagulation and thrombolysis
are themainstay of treatment with surgery limited for selected
patients. Oral anticoagulation for all and thrombolysis for high
risk thrombi associatedwithmobile fragile thrombusorwith PE
is recommended. However, in transit thrombus presenting
across PFO is themost difficult groupwith uncertain prognosis.Conflicts of interest
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